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doi:10.1016/j.jtcvs.2007.11.021448 The Journal of Thoracic and CarObjective: Treatment of central and paracentral pulmonary embolism in patients with
hemodynamic compromise remains a subject of debate, and no consensus exists
regarding the best method: thrombolytic agents, catheter-based thrombus aspiration
or fragmentation, or surgical embolectomy. We reviewed our experience with emer-
gency surgical pulmonary embolectomy.
Methods: Between January of 2000 and March of 2007, 25 patients (17 male, mean
age 60 years) underwent emergency open embolectomy for central and paracentral
pulmonary embolism. Eighteen patients presented in cardiogenic shock, 8 of whom
had cardiac arrest and required cardiopulmonary resuscitation. All patients underwent
operation with mild hypothermic cardiopulmonary bypass. Concomitant procedures
were performed in 8 patients (3 coronary artery bypass grafts, 2 patent foramen ovale
closures, 4 ligations of the left atrial appendage, 3 removals of a right atrial thrombus).
Follow-up is 96% complete with a median of 2 years (range, 2 months to 6 years).
Results: All patients survived the procedure, but 2 patients died in the hospital on
postoperative days 1 (intracerebral bleeding) and 11 (multiorgan failure), accounting
for a 30-day mortality of 8% (95% confidence interval: 0.98–0.26). Four patients died
later because of their underlying disease. Pre- and postoperative echocardiographic
pressure measurements demonstrated the reduction of the pulmonary hypertension
to half of the systemic pressure values or less.
Conclusion: Surgical pulmonary embolectomy is an excellent option for patients with
major pulmonary embolism and can be performed with minimal mortality and mor-
bidity. Even patients who present with cardiac arrest and require preoperative cardio-
pulmonary resuscitation show satisfying results. Immediate surgical desobstruction
favorably influences the pulmonary pressure and the recovery of right ventricular
function, and remains the treatment of choice for patients with massive central and
paracentral embolism with hemodynamic and respiratory compromise.
M
ortality rates after surgical pulmonary embolectomy in patients with acute
central and paracentral pulmonary embolism have decreased in recent
years. However, reported rates range from 6% to 40%, and still reach up
to 60% when the procedure is performed on critically ill patients.1-3 These high rates
of unfavorable outcome have led to more conservative treatment recommendations
for the majority of patients, reserving surgical embolectomy as a last-resort treatment
for patients in severe shock and for patients in whom less-invasive strategies have
failed.4
In contrast, a more aggressive surgical approach to massive pulmonary embolism
has been reported by others, who find surgical embolectomy reasonable treatment for
massive central and paracentral pulmonary embolism in case of hemodynamic com-
promise, but also in hemodynamically stable patients with right ventricular dysfunc-
tion.5,6
We present our institutional experience with the surgical treatment of central and
paracentral pulmonary embolism.diovascular Surgery c August 2008
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Materials and Methods
Between January of 2000 and March of 2007, 25 patients under-
went emergency surgical pulmonary embolectomy for acutemassive
pulmonary embolism. Seventeen patients weremale with amean age
of 60 years (range 22–75 years). Patients’ risk factors for the devel-
opment of pulmonary embolism are shown in Table 1.
The most frequent indications to proceed with surgical embolec-
tomy are presented in Table 2. All patients required inotropic sup-
port, and 18 patients (72%) presented in cardiogenic shock with
a shock index of greater than 1, 8 (32%) of whom experienced
cardiac arrest and required cardiopulmonary resuscitation.
The diagnosis was made by contrast spiral computed tomogra-
phy (CT) in all cases, showing bilateral and central clot burden
(Figure 1). The localization of thrombi is summarized in Table 3.
In addition, transthoracic echocardiography was performed in 19
patients and showed right ventricular dysfunction and pulmonary
hypertension (defined as a right ventricular/right atrial gradient
.30 mm Hg) in all of these patients.
Surgical Technique
Surgical embolectomy is performed through a median sternotomy
on mild hypothermic cardiopulmonary bypass (CPB) using bicaval
cannulation. The main pulmonary artery is opened with a longitudi-
nal incision, which is extended into the right or left pulmonary artery
branches if necessary. The thrombotic material is extracted bymeans
of forceps and assisting suction. To allow for complete clot removal,
the left and right pulmonary artery branches were videoscopically
inspected up to the segmental arteries in 8 cases. Massage of the
lungs is not performed to avoid additional damage to the lung paren-
chyma. Furthermore, the right atrium and ventricle are explored rou-
tinely, all clot material is carefully removed, and a patent foramen
ovale is closed in every patient. The pulmonary arteriotomy is closed
with a running suture, and the patients are weaned from CPB after
declamping.
Results
The median CPB time was 74 minutes (range, 47–144 min-
utes), and the median aortic crossclamp time was 41 minutes
(range, 27–95 minutes). Three patients underwent beating-
heart surgery. Concomitant procedures were performed in 8
patients (3 coronary artery bypass grafts, 2 patent foramen
ovale closures, 4 ligations of the left atrial appendage, 4
removals of a right atrial thrombus).
All patients survived the procedure. The 30-day mortality
was 8% (2 patients) (95% confidence interval [CI]: 0.98–
26.03). A 62-year-old female patient died of intracerebral
bleeding on postoperative day 1. She was referred after 2 un-
successful attempts of thrombolysis. A 70-year-old male pa-
tient died of aspiration pneumonia and multiorgan failure onThe Journal of Thorpostoperative day 11. This patient had also undergone unsuc-
cessful thrombolytic therapy before surgical intervention.
Both patients had undergone cardiopulmonary resuscitation
and presented preoperatively in profound cardiogenic shock
with maximal inotropic support and shock indexes of 3.3 and
2.1, respectively.
Reoperations formediastinal bleedingwere performed in 2
patients (8%). Postoperatively, all patients received anticoa-
gulation therapy starting with heparin 6 hours postoperatively
until oral anticoagulation with warfarin was fully effective
with a target international normalized ratio between 2.0 and
3.0. No filters were inserted into the inferior vena cava.
The median follow-up interval was 24 months (range,
2–85 months) and is complete in 96% (24 patients). Twelve
patients were followed for more than 2 years, 9 patients were
followed for more than 3 years, and 7 patients were followed
for more than 4 years.
There were 4 late deaths. Actuarial survival at 1 and 4
years’ follow-up was 80% (95 CI: 0.61–0.93) at 1 year and
76% (95 CI: 0.54–0.9) at 4 years. All patients with late deaths
(at 2, 4, and 5 months, and at 3 years) died of cancer.
Postoperative echocardiographic pressure measurements
demonstrated a significant reduction (P , .001) of the pul-
monary pressure to half of the systemic values or less in
all patients (n 5 13) who received preoperative and postop-
erative echocardiographic evaluation with estimation of the
pulmonary artery pressure (Figure 2). At last follow-up, all
patients were classified with New York Heart Association
TABLE 1. Risk factors for development of pulmonary
embolism (n 5 25)
Condition n (%)
Deep vein thrombosis 8 (32%)
Immobility 7 (28%)
Cancer 4 (16%)
Pregnancy 1 (4%)
Smoking history 4 (16%)
Hypercoagulability 1 (4%)
none 2 (8%)
TABLE 2. Indications for surgical embolectomy (n 5 25)
Indication n (%)
Active bleeding 1 (4%)
Recent surgical interventions 4 (16%)
Stroke 1 (4%)
Failure of thrombolytics 4 (16%)
Failure of catheter embolectomy 1 (4%)
Large RA-RV thrombus 4 (16%)
RV hemodynamic dysfunction 19 (76%)
Cardiogenic shock 18 (72%)
Cardiac arrest 8 (32%)
RA, Right atrial; RV, right ventricular.acic and Cardiovascular Surgery c Volume 136, Number 2 449
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bolism was observed.
Discussion
Early mortality after surgical pulmonary embolectomy is re-
ported to be high. Published reports state that the rate has im-
proved, ranging from 8% to 27%.5-7 However, mortality rates
are found to increase significantly to 30% to 40% when sur-
gical pulmonary embolectomy is performed in patients who
present in critical preoperative conditions. Consequently, pa-
tient selection and the level of aggressiveness pursuing with
open pulmonary embolectomy remain unclear and a subject
of debate. Criteria recommended for pulmonary embolec-
tomy are 1) massive pulmonary embolism, angiographically
documented if possible; 2) hemodynamic instability (shock)
despite heparin therapy and resuscitation efforts; and 3) the
failure of thrombolytic therapy or a contraindication to its
use (4). We think that the criteria of failure of thrombolytic
therapy is critically affecting these patients by delaying sur-
gery, and a substantial number of them require massive ino-
tropic support or even cardiopulmonary resuscitation before
surgery.
Figure 1. Embolic clot removed from a patient with bilateral mas-
sive pulmonary embolism.
TABLE 3. Localization of thrombi (n 5 25)
Localization n (%)
Right atrium 4 (16%)
Patent foramen ovale 2 (8%)
Left atrium 1 (4%)
Main pulmonary artery and bilateral extension 18 (72%)
Paracentrally in left and right pulmonary artery 7 (28%)
Superior vena cava 1 (4%)
Inferior vena cava 1 (4%)450 The Journal of Thoracic and Cardiovascular Surgery c AuOthers suggest a more aggressive approach. Leacche and
colleagues6 recommend surgical embolectomy in the pres-
ence of large central clot burden in hemodynamically stable
patients who show right ventricular dysfunction. They report
on 47 patients with an operative mortality rate of 6% (3 pa-
tients). Two of their patients had preoperative cardiac arrest,
and there were 6 late deaths (12%), mostly from metastatic
cancer.
Our observation compares favorably with these data, with
all patients surviving the procedure and a 30-day mortality of
8% (2 patients). Both early postoperative deaths were not di-
rectly related to surgery; 1 patient died of intracerebral bleed-
ing on postoperative day 1, and 1 patient died of multiorgan
failure on postoperative day 11. Both patients had undergone
two unsuccessful attempts of thrombolytic therapy.
Both patients who died early in this study had preoperative
cardiac arrest, and this underlines the strong negative impact
of preoperative cardiac arrest on the operative mortality rate
after pulmonary embolectomy. In a recent systematic review
of more than 40 reports, Stein and colleagues8 found a 59%
operative mortality rate among patients with cardiac arrest
before pulmonary embolectomy. In this study, a 29% mortal-
ity rate (2 deaths) was found among the 7 patients experienc-
ing preoperative cardiac arrest.
With regard to late death, we observed a 16% late mortal-
ity rate caused by the 4 patients’ underlying diseases, primar-
ily metastatic cancer.
The cause of early death in patients undergoing pulmonary
embolectomy has been largely attributed to right ventricular
failure secondary to persistent pulmonary hypertension, in-
terstitial pulmonary edema, and massive parenchymal and
intrabronchial hemorrhage.9,10 A proposed explanation is
Figure 2. Pre- and postoperative measurement of pulmonary
artery pressure. Pre- and postoperative echocardiographic mea-
surements with estimation of the pulmonary artery pressure
were performed in 13 patients and demonstrated the reduction
of the pulmonary hypertension to half systemic values or less in
all of these patients. PAP, Pulmonary artery pressure.gust 2008
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pulmonary arterial tree causing persistent hypertension.
The extraction of distal thrombotic material is commonly
attempted by means of Fogarty catheter extraction or manual
compression of the lungs. Both methods cannot be well con-
trolled and may cause mechanical injuries to the pulmonary
arterial wall, especially in the segmental branches, and may
provoke parenchymal and endobronchial bleeding. Spagnolo
and colleagues11 proposed retrograde pulmonary perfusion to
flush out residual thrombotic material and to prevent pulmo-
nary air embolism by a retrograde filling of the pulmonary
artery. We do not find this technique necessary and did not
use it in any of our patients. We found pulmonary arterio-
scopy to be a useful technique to localize and facilitate distal
clot extraction. We think that the most complete removal of
thrombotic material is the best predictor to avoid persistent
pulmonary artery hypertension.
In the situation of more peripherally located clot burden
and difficult removal, cooling on CPB of the patient could
also be considered to reduce CPB flow for an improved visu-
alization. However, this additional maneuver was not neces-
sary in our patients.
In regard to the postoperative anticoagulation therapy of
the patients, heparinwas started 6 hours after surgery and con-
tinued until warfarin was fully effective with a target interna-
tional normalized ratio between 2.0 and 3.0. No caval filters
were placed postoperatively. Caval filters might prevent re-
current embolism, but patients with filters are prone to de-
velop deep vein thrombosis.12,13 Therefore, the placement
of temporary caval filters might be considered in patients
who have transient contraindications to anticoagulation ther-
apy and who experience recurrent embolism despite optimal
oral anticoagulation.
In contrast with many previous studies, our results confirm
that surgical pulmonary embolectomy can be performed with
a low mortality rate in patients with massive central and para-
central pulmonary embolism, even in those who experience
cardiac arrest before surgical intervention. We think that an
essential component for this improved outcome is a multidis-
ciplinary approachwith rapid diagnosis by CT and echocardi-
ography. CT helps to identify patients with centrally localized
emboli, which are surgically accessible, whereas patients pre-
senting with the majority of the clot burden located more
peripherally might not be good candidates for a surgical inter-
vention. Echocardiography allows the identification of pa-
tients with impending right ventricular dysfunction, which
has been shown to be a strong risk factor for death.
In view of the low mortality rate revealed by more recent
reports, including the present one, and the lower number of
hemorrhagic events and lower rate of recurrent pulmonary
embolic events when compared with medical treatment in
hemodynamically compromised patients, surgical embolec-
tomy should not be reserved for patients with massiveThe Journal of Thopulmonary embolism who present in cardiogenic shock, as
advocated in the past. Unfortunately, the Trendelenburg pro-
cedure (using inflow occlusion without CPB) might still be
considered by emergency department doctors. However,
this is a heroic surgical intervention that has nothing in com-
mon with the meticulous extraction of the thrombotic mate-
rial, as currently practiced.
Conclusions
This report shows that good results can be achieved with sur-
gery in patients with pulmonary embolism and hemodynamic
instability. A multidisciplinary approach is an essential com-
ponent of the management, and the application of angioscopy
allows for an optimized clot removal. Furthermore, extension
of the indication for surgical pulmonary embolectomy should
be considered beyond the traditional indications, such as fail-
ure of lytic treatment or hemodynamic compromise, even to
hemodynamically stable patients with right ventricular dys-
function and a high clot burden in the central pulmonary
arteries.
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